Advanced Biomedical Technologies, Inc. announced that it has received approval from the China Food and Drug Administration (“CFDA”) for its polymer orthopaedic internal fixation screws. The composite material developed by the company is the only biomaterial of its kind in the current market of human internal fixation devices. It consists of PA6-P(MMA-CO-NVP)-HA and is distinctively fiber-reinforced. The CFDA approval presents the company with clinical and financial potential, and advances the mission to provide innovative products to patients that address the full continuum of orthopaedic care.